Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05813730

Urinary Creatinine Excretion Time in the Neonatal Period

Definition of Urinary Creatinine Excretion Time in the Neonatal Period, in Full Term Newborns : a Prospective Monocentric Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
3 Days
Healthy volunteers
Accepted

Summary

Newborn's renal function is difficult to assess and its physiology during the first days of life is still incompletely known. Studies suggest that the newborn almost completely reabsorbs creatinine during the first 48 to 72 hours of life, while at the same time it continues to produce its own creatinine. Therefore, the initial stock of creatinine at birth still increases through this production and the non or weak clearance. A better knowledge of renal physiopathology in newborns would allow to improve the therapeutic management of the infants, particularly in case of potential nephrotoxicity. No study has attempted to assess the increase in urinary creatinine excretion in neonates from a given time. Objectives: To show when urinary creatinine excretion in newborns is efficient. Results: this study mightr show an inflection point in urinary creatinine excretion illustrating the postnatal age when renal function becomes efficient.

Conditions

Interventions

TypeNameDescription
OTHERurinary creatinine excretion measurementUrine samples will be collected up to 6 times a day from birth until discharge from the maternity hospital, to analyze the kinetics of creatinuria.

Timeline

Start date
2024-10-30
Primary completion
2025-11-01
Completion
2025-12-01
First posted
2023-04-14
Last updated
2025-02-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05813730. Inclusion in this directory is not an endorsement.

Urinary Creatinine Excretion Time in the Neonatal Period (NCT05813730) · Clinical Trials Directory